Results 291 to 300 of about 509,731 (381)

Differences in perceived chromatic aberration between emmetropic and myopic eyes using adaptive optics. [PDF]

open access: yesFront Med (Lausanne)
Rodriguez-Lopez V   +3 more
europepmc   +1 more source

Molecular Aberrations in Periampullary Carcinoma

open access: green, 2017
Mallika Tewari   +3 more
openalex   +2 more sources

Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The placebo response in clinical trials in ataxias complicates outcome interpretation and potentially obscures genuine treatment effects. We analyzed placebo group data from past trials in Friedreich Ataxia and observed notable responses in appendicular items, in contrast to minimal changes in axial function, as measured by respective ...
Christian Rummey   +2 more
wiley   +1 more source

Corneal epithelial aberrations: a novel diagnostic tool for keratoconus and forme fruste keratoconus. [PDF]

open access: yesEye Vis (Lond)
Ning R   +10 more
europepmc   +1 more source

Health‐Related Quality of Life in Rare Forms of Childhood‐Onset Hereditary Spastic Paraplegia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We assessed health‐related quality of life (HRQoL) in 80 children with rare hereditary spastic paraplegias using the Caregiver Priorities and Child Health Index of Life with Disabilities and clinician‐reported outcomes. HRQoL was consistently reduced, particularly in relation to motor, autonomic, and bulbar symptoms.
Henri J. D. Schmidt   +11 more
wiley   +1 more source

Evaluation Method for Resin Mold Using Reflective Wavefront Sensor. [PDF]

open access: yesSensors (Basel)
Tatsumi K   +6 more
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Neural network enabled wide field-of-view imaging with hyperbolic metalenses. [PDF]

open access: yesNanophotonics
Yeo J   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy